Martha Lamm

837 total citations
11 papers, 605 citations indexed

About

Martha Lamm is a scholar working on Surgery, Gastroenterology and Rheumatology. According to data from OpenAlex, Martha Lamm has authored 11 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 9 papers in Gastroenterology and 2 papers in Rheumatology. Recurrent topics in Martha Lamm's work include Gastroesophageal reflux and treatments (9 papers), Eosinophilic Esophagitis (8 papers) and Helicobacter pylori-related gastroenterology studies (5 papers). Martha Lamm is often cited by papers focused on Gastroesophageal reflux and treatments (9 papers), Eosinophilic Esophagitis (8 papers) and Helicobacter pylori-related gastroenterology studies (5 papers). Martha Lamm collaborates with scholars based in Sweden, Denmark and Finland. Martha Lamm's co-authors include Pekka Miettinen, Kristina Levander, Bengt Liedman, Lars Lundell, Jonas Carlsson, I Wiklund, A. Walan, Niilo Havu, Elly C. Klinkenberg–Knol and G.F. Nelis and has published in prestigious journals such as Gastroenterology, Gut and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Martha Lamm

11 papers receiving 565 citations

Peers

Martha Lamm
Martha Lamm
Citations per year, relative to Martha Lamm Martha Lamm (= 1×) peers Kristina Levander

Countries citing papers authored by Martha Lamm

Since Specialization
Citations

This map shows the geographic impact of Martha Lamm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martha Lamm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martha Lamm more than expected).

Fields of papers citing papers by Martha Lamm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martha Lamm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martha Lamm. The network helps show where Martha Lamm may publish in the future.

Co-authorship network of co-authors of Martha Lamm

This figure shows the co-authorship network connecting the top 25 collaborators of Martha Lamm. A scholar is included among the top collaborators of Martha Lamm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martha Lamm. Martha Lamm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Lundell, Lars, Niilo Havu, Pekka Miettinen, et al.. (2006). Changes of gastric mucosal architecture during long‐term omeprazole therapy: results of a randomized clinical trial. Alimentary Pharmacology & Therapeutics. 23(5). 639–647. 71 indexed citations
3.
Hawkey, C J, Neville D. Yeomans, Roger Jones, et al.. (2003). Esomeprazole improves quality of life in patients with upper GI symptoms associated with long-term NSAID therapy. Gastroenterology. 124(4). A107–A107. 7 indexed citations
4.
Yeomans, Neville D., C J Hawkey, Roger Jones, et al.. (2003). Esomeprazole provides effective control of NSAID-associated upper GI symptoms in patients continuing to take NSAIDs. Gastroenterology. 124(4). A107–A107. 11 indexed citations
5.
Nelis, G.F., Elly C. Klinkenberg–Knol, P. Snel, et al.. (2001). Helicobacter pylori eradication for the prevention of atrophic gastritis during omeprazole therapy; A prospective randomized trial. Gastroenterology. 120(5). A14–A14. 6 indexed citations
6.
Lundell, Lars, Pekka Miettinen, Bengt Liedman, et al.. (2001). Continued (5-Year) Followup of A Randomized Clinical Study Comparing Antireflux Surgery and Omeprazole in Gastroesophageal Reflux Disease. Journal of the American College of Surgeons. 192(2). 172–179. 256 indexed citations
7.
Lundell, L, Pekka Miettinen, H. E. Myrvold, et al.. (2000). Long-term management of gastro-oesophageal reflux disease with omeprazole or open antireflux surgery: results of a prospective, randomized clinical trial. European Journal of Gastroenterology & Hepatology. 12(8). 879–887. 84 indexed citations
8.
Lundell, Lars, Pekka Miettinen, H. E. Myrvold, et al.. (2000). Continued (5 years) follow-up of a randomised clinical study comparing anti-reflux surgery and omeprazole in gastroesophageal reflux disease. Gastroenterology. 118(4). A191–A191. 6 indexed citations
9.
Miettinen, Pekka, Lars Lundell, H. E. Myrvold, et al.. (2000). Factors predicting relapse of gerd after antireflux surgery and during medical treatment. Results of a randomised multi-center trial. Gastroenterology. 118(4). A191–A191. 2 indexed citations
10.
Walan, A., Niilo Havu, Lars Lundell, et al.. (2000). Vitamin B12 levels during long-term treatment with omeprazole or after anti-reflux surgery in patients with gerd. Results of a randomised study. Gastroenterology. 118(4). A219–A219. 1 indexed citations
11.
Lundell, Lars, Niilo Havu, Pekka Miettinen, et al.. (2000). No effect of acid suppression therapy over five years on gastric glandular atrophy. Results of a randomised clinical study. Gastroenterology. 118(4). A214–A214. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026